How Do Zotefoams plc’s (LON:ZTF) Returns Compare To Its Industry?

Today we'll evaluate Zotefoams plc (LON:ZTF) to determine whether it could have potential as an investment idea. In particular, we'll consider its Return On Capital Employed (ROCE), as that can give us insight into how profitably the company is able to employ capital in its business.

Firstly, we'll go over how we calculate ROCE. Then we'll compare its ROCE to similar companies. Finally, we'll look at how its current liabilities affect its ROCE.

Advertisement

Understanding Return On Capital Employed (ROCE)

ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. All else being equal, a better business will have a higher ROCE. Overall, it is a valuable metric that has its flaws. Author Edwin Whiting says to be careful when comparing the ROCE of different businesses, since 'No two businesses are exactly alike.'

So, How Do We Calculate ROCE?

Analysts use this formula to calculate return on capital employed:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

Or for Zotefoams:

0.097 = UK£11m ÷ (UK£140m - UK£21m) (Based on the trailing twelve months to June 2019.)

So, Zotefoams has an ROCE of 9.7%.

View our latest analysis for Zotefoams

Is Zotefoams's ROCE Good?

When making comparisons between similar businesses, investors may find ROCE useful. Using our data, Zotefoams's ROCE appears to be significantly below the 12% average in the Chemicals industry. This performance could be negative if sustained, as it suggests the business may underperform its industry. Regardless of where Zotefoams sits next to its industry, its ROCE in absolute terms appears satisfactory, and this company could be worth a closer look.

LSE:ZTF Past Revenue and Net Income, August 26th 2019
LSE:ZTF Past Revenue and Net Income, August 26th 2019

When considering this metric, keep in mind that it is backwards looking, and not necessarily predictive. ROCE can be deceptive for cyclical businesses, as returns can look incredible in boom times, and terribly low in downturns. ROCE is, after all, simply a snap shot of a single year. What happens in the future is pretty important for investors, so we have prepared a free report on analyst forecasts for Zotefoams.

What Are Current Liabilities, And How Do They Affect Zotefoams's ROCE?

Current liabilities include invoices, such as supplier payments, short-term debt, or a tax bill, that need to be paid within 12 months. The ROCE equation subtracts current liabilities from capital employed, so a company with a lot of current liabilities appears to have less capital employed, and a higher ROCE than otherwise. To counter this, investors can check if a company has high current liabilities relative to total assets.

Zotefoams has total assets of UK£140m and current liabilities of UK£21m. As a result, its current liabilities are equal to approximately 15% of its total assets. Low current liabilities are not boosting the ROCE too much.

What We Can Learn From Zotefoams's ROCE

This is good to see, and with a sound ROCE, Zotefoams could be worth a closer look. Zotefoams shapes up well under this analysis, but it is far from the only business delivering excellent numbers . You might also want to check this free collection of companies delivering excellent earnings growth.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap. cover
138
PR
pri_dlp7z

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.

QU
Quantanium

There’s a 60% to 85% probability of the vaccine being approved based on historical drug development data. Could be a lot of scrutiny by the FDA due to the novel platform used.

Market might be getting a little ahead of itself here.

About LSE:ZTF

Zotefoams

Manufactures, distributes, and sells foam materials in Europe, the Middle East, Africa, North America, and Asia.

Very undervalued with flawless balance sheet.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$520.6% undervalued
54 users have followed this narrative
2 users have commented on this narrative
7 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.9% undervalued
99 users have followed this narrative
2 users have commented on this narrative
15 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8913.6% undervalued
13 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k25.0% undervalued
38 users have followed this narrative
0 users have commented on this narrative
12 users have liked this narrative

Updated Narratives

AR
MRT logo
ariz_scribe on Marti Technologies ·

$MRT at Roth - Pick of the Panel

Fair Value:US$1.960% overvalued
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
AIIO logo
david_1211213 on Robo.ai ·

Robo.ai (AIIO): A Long-Term Bullish Technical Setup

Fair Value:US$5.6449.8% undervalued
1 users have followed this narrative
7 users have commented on this narrative
1 users have liked this narrative
RO
RockeTeller
WRLG logo
RockeTeller on West Red Lake Gold Mines ·

This Junior Gold Mine Just Hit Commercial Production, 120k oz Roadmap at $7,000 Gold

Fair Value:CA$4.3681.4% undervalued
27 users have followed this narrative
8 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
331 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9115.3% overvalued
184 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0944.0% undervalued
209 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative